Author

Raja Atreya 1

1 Friedrich-Alexander-University of Erlangen-Nürnberg,Erlangen,Germany

A SYSTEMATIC REVIEW AND META-ANALYSIS OF THE EFFICACY AND SAFETY OF INFLIXIMAB AND VEDOLIZUMAB IN PATIENTS WITH INFLAMMATORY BOWEL DISEASE

Laurent Peyrin-Biroulet, Alessandro Armuzzi, Raja Atreya, Silvio Danese, Jordi Guardiola, Jørgen Jahnsen, Charlie Lees, Edouard Louis, Milan Lukas, Walter Reinisch, Xavier Roblin, Minyoung Jang, Han Geul Byun

Anti-IL23 and more

Raja Atreya

ANTI-TNF ALPHA THERAPY IN BIOLOGICS-NAϊVE ULCERATIVE COLITIS PATIENTS IN A PROSPECTIVE “REAL WORLD” STUDY IN GERMANY (BIOCOLITIS-REGISTRY)

Bernd Bokemeyer, Raja Atreya, Jürgen Büning, Tanja Kühbacher, Christian Maaser, Karen Schmidt, Petra Hartmann, Berit Wiebe, Stefan Schreiber

Assessing mucosal barrier function in vivo with confocal laser endomicroscopy can predict major clinical events in IBD patients with high sensitivity

Timo Rath, Entcho Klenske, Raja Atreya, Sarahh Fischer, Sebastian Zundler, Arndt Hartmann, Markus F. Neurath

BLOCKADE OF ?E?7 INTEGRIN CONTROLS TRAFFICKING OF CD8+ AND TH9 LYMPHOCYTES FROM IBD PATIENTS TO THE INFLAMED GUT IN VIVO

Sebastian Zundler, Anika Fischer, Raja Atreya, Rocío Lopez-Posadas, Alastair Watson, Clemens Neufert, Imke Atreya, Markus F. Neurath

BURDEN OF BOWEL URGENCY ACROSS SPECIFIC TREATMENT GROUPS AMONG CROHN’S DISEASE PATIENTS – REAL WORLD GLOBAL STUDY ANALYSES

Raja Atreya, Marijana Protic, Petra Streit, Susanne Hartz, Hannah Knight, Sophie Barlow, Fritha Hennessy, Theresa Hunter Gibble

BURDEN OF BOWEL URGENCY ACROSS SPECIFIC TREATMENT GROUPS AMONG CROHN’S DISEASE PATIENTS – REAL WORLD GLOBAL STUDY ANALYSES

Raja Atreya

CD4+ T CELLS OF IBD PATIENTS ARE CHARACTERIZED BY AN INCREASED EXPRESSION OF THE NUCLEOTIDE RECEPTOR P2Y2, WHICH IMPACTS RELEVANTLY ON PRO-INFLAMMATORY SIGNALING CASCADES.

Julia Panteleev-Ivlev, Sebastian Zundler, Raja Atreya, Markus Friedrich Neurath, Imke Atreya

CLINICAL DISEASE ACTIVITY INFLUENCES THE THERAPEUTIC EFFICACY OF THE TOLL LIKE RECEPTOR-9 AGONIST COBITOLIMOD IN PATIENTS WITH MODERATE TO SEVERE ACTIVE ULCERATIVE COLITIS

Raja Atreya, Laurent Peyrin-Biroulet, Walter Reinisch, Franco Scaldaferri, Charlotte Admyre, Thomas Knittel, Jan Kowalski, Markus F. Neurath, Christopher John Hawkey

CLINICAL EFFICACY OF THE TOLL LIKE RECEPTOR-9 AGONIST COBITOLIMOD IN ANTI-TNF-ANTIBODY TREATED AND NAIVE PATIENTS WITH MODERATE TO SEVERE ACTIVE ULCERATIVE COLITIS

Raja Atreya

Item 1 - 10 / 56
1
2 3 4 5 6